Cosmo Godino։ Aortic Stenosis Is More Than a Valve Disease
Cosmo Godino, Medical Doctor at San Raffaele Hospital, shared a post on LinkedIn:
”For years, we have defined aortic stenosis using rigid cut-offs: AVA less than 1 cm²Mean gradient greater than 40 mmHg.
But clinical practice teaches us something different.
Some patients with ‘only’ moderate aortic stenosis are highly symptomatic, develop pulmonary hypertension, myocardial damage, heart failure, and experience major cardiovascular events.
Meanwhile, others with similar valve parameters remain relatively stable.
Why?
Because aortic stenosis is not just a valve disease.
The impact on the myocardium, filling pressures, pulmonary circulation, renal function, associated valvular disease and overall patient complexity may matter more than the valve gradient itself.
Our recently published SPARK score moves in this direction: a broader and more tailored evaluation of patients with moderate AS.
Medicine is changing.
We need to move beyond old and limited cut-offs toward a more patient-centered and individualized approach.
Because we should treat patients – not numbers.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention